A phase 2b, randomized, double-blind, placebo-controlled multicenter study evaluating antiviral effects, pharmacokinetics, safety, and tolerability of presatovir in hematopoietic cell transplant recipients with respiratory syncytial virus (RSV) infection of the lower respiratory tract - Marty, F M; Chemaly, R F; Mullane, K M (Clin Infect Dis, 2019)
(e-pub ahead of print)